| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,107 | -5.95% | |
| 6 months | ₹30,000 | ₹26,386 | -12.05% | |
| 1 year | ₹60,000 | ₹53,898 | -10.17% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| SMS Pharmaceuticals Ltd. | Healthcare | Equity | 9.98% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 9.25% |
| Viyash Scientific Limited | Healthcare | Equity | 9.05% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 8.34% |
| Zydus Wellness Ltd. | Consumer Staples | Equity | 7.05% |
| Pfizer Ltd. | Healthcare | Equity | 6.93% |
| Alivus Life Sciences Ltd | Healthcare | Equity | 6.41% |
| ICICI Prudential Life Insurance Company Ltd. | Insurance | Equity | 5.56% |
| Aurobindo Pharma Ltd. | Healthcare | Futures | 5.36% |
| Biocon Ltd. | Healthcare | Futures | 4.89% |
| HDFC Life Insurance Co Ltd. | Insurance | Equity | 4.65% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 4.54% |
| HDFC Life Insurance Co Ltd. | Insurance | Futures | 4.49% |
| Medplus Health Services Ltd. | Healthcare | Equity | 3.63% |
| Concord Biotech Ltd. | Healthcare | Equity | 2.91% |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 2.38% |
| ICICI Prudential Life Insurance Company Ltd. | Insurance | Futures | 1.95% |
| Reserve Bank of India | Financial | T-Bills | 1.69% |
| Gland Pharma Ltd. | Healthcare | Equity | 1.46% |
| Reserve Bank of India | Financial | T-Bills | 0.85% |
| Reserve Bank of India | Financial | T-Bills | 0.85% |
| Reserve Bank of India | Financial | T-Bills | 0.85% |
| Reserve Bank of India | Financial | T-Bills | 0.85% |
| Reserve Bank of India | Financial | T-Bills | 0.57% |
| Adani Enterprises Ltd. - (Partly Paid-up) | Services | PPE | 0.56% |
| Reserve Bank of India | Financial | T-Bills | 0.29% |
| Reserve Bank of India | Financial | T-Bills | 0.28% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | -4.1% | -6.9% | +9.2% | +50.8% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 17 | 23 | 13 | -- |